
Ask a doctor about a prescription for CLOZAPINE AUROVITAS 200 mg TABLETS
Package Leaflet: Information for the Patient
Clozapine Aurovitas 200 mg Tablets
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Contents of the pack and additional information
The active substance of Clozapine Aurovitas is clozapine, which belongs to a group of medications called antipsychotics (medications used to treat specific mental disorders, such as psychosis).
Clozapine is used to treat patients with schizophrenia when the use of other medications has not been effective. Schizophrenia is a mental illness that affects how you think, feel, and behave. You should only use this medication if you have already tried at least two other antipsychotic medications, including one of the new atypical antipsychotics to treat schizophrenia, and these medications did not work or caused severe side effects that cannot be treated.
Do not take Clozapine Aurovitas if:
Tell your doctor and do not take clozapine if any of the above circumstances apply to you.
Clozapine should not be administered to anyone who is unconscious or in a coma.
Warnings and Precautions
The safety measures mentioned in this section are very important. You must comply with them to minimize the risk of severe side effects that can be life-threatening.
Before starting treatment with Clozapine Aurovitas,tell your doctor if you have or have had:
Before taking the next dose of Clozapine Aurovitas tablets, immediately inform your doctor if:
Medical Exams and Blood Tests
Before starting treatment with clozapine, your doctor will ask about your medical history and perform a blood test to ensure that your white blood cell count is normal. It is essential to know this, as you need white blood cells to fight infections.
Make sure you have regular blood tests before, during, and after finishing treatment with clozapine.
Before starting treatment, your doctor will also perform a physical examination. Your doctor may perform an electrocardiogram (ECG) to examine your heart, but only if it is necessary for you or if you have a special concern.
If you have liver problems, you will have periodic liver function tests throughout treatment with clozapine.
If you have high blood sugar levels (diabetes), your doctor may perform periodic checks of your blood sugar levels.
Clozapine can alter blood lipid levels. Clozapine can cause weight gain. Your doctor may monitor your weight and lipid levels.
If you feel dizzy, lightheaded, or lose consciousness, or clozapine makes you feel this way, be careful when getting up from a sitting or lying position, as this can increase the risk of falls.
If you need to have surgery or if you cannot walk for a long period, tell your doctor that you are taking clozapine. You may be at risk of having a blood clot (thrombosis).
Children and Adolescents Under 16 Years
If you are under 16 years old, you should not take clozapine, as there is not enough information available for its use in this age group.
Elderly Patients (60 Years and Older)
Elderly patients (60 years and older) may be more prone to experiencing the following side effects during treatment with clozapine: weakness or dizziness after changing position, dizziness, rapid heartbeat, difficulty urinating, and constipation.
Tell your doctor or pharmacist if you suffer from a disease called dementia.
Other Medications and Clozapine Aurovitas
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication. This includes medications purchased without a prescription or herbal remedies. You may need to take a different amount of your medications or different medications.
Do not take Clozapine Aurovitas with other medications that prevent the proper functioning of the bone marrow and/or decrease the number of blood cells produced by the body,such as:
These medications increase your risk of developing agranulocytosis (low white blood cell count).
Taking clozapine at the same time as other medications can affect the proper action of clozapine and/or the other medications. Inform your doctor if you intend to take, are taking (even if treatment is about to finish), or have recently stopped taking any of the following medications:
This list is not complete. Your doctor and pharmacist have more information about medications that should be administered with caution or avoided while taking clozapine. They also know if the medications you are taking belong to any of the groups listed above. Discuss this with them.
Taking Clozapine Aurovitas with Food and Drinks
During treatment with clozapine, do not drink alcohol.
Tell your doctor if you smoke and how often you consume caffeinated beverages (coffee, tea, cola). Suddenly changing your smoking or caffeinated beverage habits can also change the effects of clozapine.
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication. Your doctor will discuss the benefits and possible risks of using this medication during pregnancy. Inform your doctor immediately if you become pregnant during treatment with clozapine.
The following symptoms may occur in newborns of mothers who have used clozapine in the last trimester (the last three months of pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
Some women who take certain medications for mental illnesses have irregular or absent menstrual periods. If this has happened to you, your menstrual period will return to normal when your medication is replaced with clozapine. This means you should use effective contraceptives.
During treatment with clozapine, you should not breastfeed your baby. Clozapine, the active substance of Clozapine Aurovitas, can pass into breast milk and affect the baby.
Driving and Using Machines
Clozapine can cause fatigue, drowsiness, and seizures, especially at the start of treatment. You should not drive or use machines while experiencing these symptoms.
Clozapine Aurovitas Contains Lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
To reduce the risk of suffering from hypotension, seizures, and somnolence, it is necessary for your doctor to gradually increase the dose. Follow exactly the administration instructions of clozapine as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
It is essential that you do not change the dose or stop taking clozapina without asking your doctor first. Continue taking the tablets for the time your doctor has indicated.
If you are a patient over 60 years old, your doctor may start your treatment with a lower dose and increase your dose more gradually, as you may be more susceptible to developing some unexpected adverse reactions (see section 2 "What you need to know before taking Clozapina Aurovitas").
If with this presentation of tablets you cannot reach the prescribed dose, other presentations of this medication are available to reach the prescribed dose.
Schizophrenia Treatment
Treatment is started with 12.5 mg (half of a 25 mg tablet) once or twice on the first day, followed by 25 mg once or twice on the second day. Swallow the tablet with a glass of water. If you tolerate it well, your doctor will gradually increase the dose in amounts of 25-50 mg over the next 2-3 weeks until reaching a daily dose of 300 mg. Then, it may be necessary to increase the daily dose in amounts of 50 mg to 100 mg twice a week, or preferably once a week.
The effective daily dose is usually between 200 mg and 450 mg, divided into several single doses per day. Some people may need higher doses. Doses of up to 900 mg per day are allowed. At daily doses above 450 mg, adverse reactions may increase (particularly seizures). Always take the minimum dose that is effective for you. Most patients should take part of the dose in the morning and another part at night. Your doctor will tell you exactly how to divide your daily dose. If your daily dose does not exceed 200 mg, you can take it as a single dose at night. Once the treatment with clozapine is working well for some time, your doctor may try to reduce the dose. You will need to take clozapine for at least 6 months.
If You Take More Clozapina Aurovitas Than You Should
If you think you have taken more clozapine than you should, or if someone has taken some of your tablets, inform your doctor immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
The symptoms of overdose are:
Somnolence, fatigue, lack of energy, unconsciousness, coma, confusion, hallucinations, agitation, incoherent speech, numbness in the limbs, tremors in the hands, seizures, increased saliva production, dilated pupils, blurred vision, low blood pressure, collapse, rapid or irregular heartbeat, shallow or difficult breathing.
If You Miss a Dose of Clozapina Aurovitas
If you miss a dose, take the missed dose as soon as possible. If it is close to the time for the next dose, do not take the missed dose and take the next dose at the scheduled time. Do not take a double dose to make up for the missed dose. If you have stopped taking clozapina for two or more days, consult your doctor.
If You Interrupt Treatment with Clozapina Aurovitas
Do not interrupt treatment with clozapina without asking your doctor, as you may have withdrawal symptoms.
These symptoms include sweating, headache, nausea, vomiting, and diarrhea. If you experience any of these symptoms, consult your doctor immediately. These symptoms can be followed by more severe ones unless treated immediately. Your initial symptoms may recur. If you need to interrupt treatment, it is recommended to gradually decrease the dose in amounts of 12.5 mg over a period of 1 to 2 weeks. Your doctor will give you instructions on how to reduce your daily dose. If you need to interrupt your treatment with clozapina suddenly, your doctor will review you. If your doctor decides to restart treatment with clozapina and your last dose was two days or more ago, you will need to start with the initial dose of 12.5 mg.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can produce adverse effects, although not all people suffer from them.
Some adverse effects can be serious and require immediate medical attention:
Tell your doctor immediately before taking the next clozapine tablet if you experience any of the following circumstances:
Very Common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Rare: may affect up to 1 in 1,000 peopleor very rare: may affect up to 1 in 10,000 people
Very Rare: may affect up to 1 in 10,000 patients
Frequency Not Known (cannot be estimated from the available data):
If any of the above cases apply to you, inform your doctor immediately before taking the next clozapine tablet.
Other Adverse Effects
Very Common: may affect more than 1 in 10 people
Somnolence, dizziness, increased saliva production.
Common: may affect up to 1 in 10 people
High levels of white blood cells in the blood (leukocytosis), high levels of a certain type of white blood cells in the blood (eosinophilia), weight gain, blurred vision, headache, tremors, rigidity, restlessness, seizures, sudden movements, abnormal movements, inability to initiate movement, inability to remain still, changes in the electrocardiogram (ECG) test of the heart, high blood pressure, dizziness or fainting after changing position, nausea, vomiting, loss of appetite, dry mouth, minor anomalies in liver function tests, loss of bladder control, difficulty urinating, fatigue, fever, increased sweating, elevated body temperature, speech disorders (e.g., difficulty articulating words).
Uncommon: may affect up to 1 in 100 people
Low white blood cell count in the blood (agranulocytosis), speech disorder (e.g., stuttering).
Rare: may affect up to 1 in 1,000 people
Low red blood cell count in the blood (anemia), restlessness, agitation, confusion, delirium, irregular heartbeat, inflammation of the heart muscle (myocarditis) or the membrane surrounding the heart muscle (pericarditis), fluid accumulation around the heart (pericardial effusion), high blood sugar levels, diabetes mellitus, blood clots in the lungs (pulmonary thromboembolism), liver inflammation (hepatitis), liver disease that causes yellowing of the skin/dark urine/itching, elevated levels in the blood of an enzyme called creatine phosphokinase.
Very Rare: may affect up to 1 in 10,000 patients
Increased number of platelets in the blood with possible blood vessel coagulation, uncontrolled movements of the mouth/tongue and limbs, obsessive thoughts and repetitive compulsive behaviors (obsessive-compulsive symptoms), skin reactions, swelling in the front of the ear (due to inflammation of the salivary glands), difficulty breathing, very high levels of triglycerides or cholesterol in the blood, heart muscle disease (cardiomyopathy), cardiac arrest, sudden unexpected death.
Frequency Not Known (cannot be estimated from the available data):
Changes in brain wave recordings (electroencephalogram/EEG), diarrhea, stomach discomfort, burning, stomach discomfort after eating, muscle weakness, muscle spasms, muscle pain, nasal congestion, nocturnal enuresis, sudden and uncontrollable increase in blood pressure (pseudopheochromocytoma), involuntary contraction that causes the body to curve to one side (pleurothotonos), if you are a man, ejaculation disorder, in which semen enters the bladder instead of being ejaculated through the penis (dry orgasm or retrograde ejaculation), rash, red-purple spots, fever, or itching due to inflammation of the blood vessels, colon inflammation that causes diarrhea, abdominal pain, fever, change in skin color, butterfly-shaped rash on the face, joint pain, muscle pain, fever, and fatigue (lupus erythematosus), restless legs syndrome (irresistible urge to move the legs or arms, usually accompanied by uncomfortable sensations during rest periods, especially in the afternoon or evening, and which is temporarily relieved by movement).
In elderly patients with dementia, a small increase in the number of deaths has been reported in patients taking antipsychotics compared to those who do not take them.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and blister after CAD. The expiration date is the last day of the month indicated.
Store below 30 ºC.
Do not use this medication if you notice any change in the appearance of the tablets.
Medications should not be thrown down the drain or into the trash. Deposit the containers and medications you no longer need in the SIGRE Point of the pharmacy. Ask your pharmacist how to dispose of the containers and medications you no longer need. This way, you will help protect the environment.
Composition ofClozapina Aurovitas
Appearance of the Product and Container Content
Uncoated tablets, pale yellow in color, oval, engraved on one side with a "C" and a "Z" with a notch in the middle and "200" on the other side. The tablet can be divided into two equal doses.
Clozapina Aurovitas 200 mg tablets are available in blisters.
Container Sizes:
Blister: 7, 14, 20, 28, 30, 40, 50, 60, 90, 100, 250, and 1,000 tablets.
PEAD Bottle:30, 50, 100, and 250 tablets.
Only some container sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Phone: 91 630 86 45
Manufacturer:
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
Or
Arrow Generiques – Lyon
26 avenue Tony Garnier,
Lyon, 69007
France
Or
Generis Farmacêutica, S.A.
Rua João de Deus, 19
2700-487 Amadora
Portugal
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Germany: Clozapin PUREN 200 mg Tabletten
Spain: Clozapina Aurovitas 200 mg tablets
France: Clozapine Arrow 200 mg comprimé sécable
Netherlands: Clozapine Auro 200 mg tabletten
Portugal: Clozapina Aurovitas
Date of the Last Revision of this Leaflet: September 2021
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)
The average price of CLOZAPINE AUROVITAS 200 mg TABLETS in November, 2025 is around 28.35 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for CLOZAPINE AUROVITAS 200 mg TABLETS – subject to medical assessment and local rules.